Nexthera Capital as of June 30, 2018
Portfolio Holdings for Nexthera Capital
Nexthera Capital holds 44 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 29.5 | $190M | 2.0M | 95.19 | |
| Allergan | 5.7 | $37M | 222k | 166.72 | |
| Immunomedics | 4.9 | $32M | 1.3M | 23.67 | |
| Exelixis (EXEL) | 4.7 | $31M | 1.4M | 21.52 | |
| BioMarin Pharmaceutical (BMRN) | 4.4 | $28M | 300k | 94.20 | |
| Dova Pharmaceuticals | 3.8 | $25M | 820k | 29.92 | |
| Tesaro | 3.0 | $19M | 434k | 44.47 | |
| AstraZeneca (AZN) | 2.8 | $18M | 520k | 35.11 | |
| Global Blood Therapeutics In | 2.8 | $18M | 404k | 45.20 | |
| Pacira Pharmaceuticals (PCRX) | 2.8 | $18M | 567k | 32.05 | |
| Alexion Pharmaceuticals | 2.5 | $17M | 133k | 124.15 | |
| Mylan Nv | 2.4 | $16M | 432k | 36.14 | |
| Cellectis S A (CLLS) | 2.4 | $16M | 548k | 28.29 | |
| Insmed (INSM) | 2.4 | $15M | 647k | 23.65 | |
| Sangamo Biosciences (SGMO) | 2.4 | $15M | 1.1M | 14.20 | |
| Sage Therapeutics (SAGE) | 1.9 | $12M | 79k | 156.53 | |
| Esperion Therapeutics (ESPR) | 1.7 | $11M | 287k | 39.19 | |
| Cymabay Therapeutics | 1.7 | $11M | 829k | 13.42 | |
| Abeona Therapeutics | 1.6 | $10M | 627k | 16.00 | |
| Audentes Therapeutics | 1.4 | $9.2M | 242k | 38.21 | |
| Catalyst Biosciences | 1.4 | $9.2M | 787k | 11.67 | |
| D Stemline Therapeutics | 1.4 | $9.0M | 560k | 16.05 | |
| Fibrogen (FGEN) | 1.3 | $8.5M | 136k | 62.60 | |
| Cara Therapeutics (CARA) | 1.3 | $8.3M | 436k | 19.15 | |
| Endocyte | 1.3 | $8.2M | 596k | 13.80 | |
| Kura Oncology (KURA) | 1.1 | $6.9M | 382k | 18.20 | |
| Seattle Genetics | 1.1 | $6.8M | 102k | 66.39 | |
| Corcept Therapeutics Incorporated (CORT) | 0.8 | $5.3M | 335k | 15.72 | |
| Deciphera Pharmaceuticals | 0.8 | $5.1M | 130k | 39.35 | |
| Akorn | 0.7 | $4.5M | 270k | 16.59 | |
| Acorda Therapeutics | 0.7 | $4.3M | 148k | 28.70 | |
| Sol Gel Technologies (SLGL) | 0.6 | $4.0M | 515k | 7.72 | |
| Oncosec Med | 0.6 | $3.6M | 2.6M | 1.38 | |
| Zosano Pharma Corp | 0.4 | $2.9M | 700k | 4.08 | |
| Neos Therapeutics | 0.4 | $2.4M | 379k | 6.25 | |
| Magenta Therapeutics | 0.3 | $2.0M | 150k | 13.50 | |
| Tg Therapeutics (TGTX) | 0.2 | $1.6M | 122k | 13.14 | |
| Aerpio Pharmaceuticals | 0.2 | $1.2M | 299k | 4.15 | |
| Versartis | 0.2 | $1.0M | 500k | 2.03 | |
| Molecular Templates | 0.1 | $902k | 172k | 5.23 | |
| Kiniksa Pharmaceuticals | 0.1 | $680k | 39k | 17.36 | |
| Corbus Pharmaceuticals Hldgs | 0.1 | $678k | 134k | 5.05 | |
| Mediwound Ltd cmn | 0.1 | $308k | 45k | 6.91 | |
| Avrobio Ord (AVRO) | 0.0 | $286k | 10k | 28.60 |
